An expert panel of the US Food and Drug Administration will be offering advice on the appropriateness of an emergency use authorization of a COVID-19 vaccine and the safety and effectiveness data needed for approval before the agency has received an application.
FDA announced that the Vaccines and Related Biologics advisory committee will convene on 22 October to “discuss, in general, the...







